Head & Neck Cancer
  • Featured content
    In this CME-certified module with accompanying downloadable slideset, Todd M. Bauer, MD, provides expert insights on the biologic role of TRK fusions in cancer along with emerging clinical trial data on TRK-targeted therapies across multiple tumor types.
  • Featured content
    Download these slides on the biologic role of TRK fusions in cancer along with emerging clinical trial data on TRK-targeted therapies across multiple tumor types.
    Date Posted: 4/16/2018
  • Featured content
    In these downloadable slides, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
    Date Posted: 11/16/2017
  • Featured content
    In this downloadable slideset, Richard Finn, MD; Leora Horn, MD, MSc, FRCPC; Yelena Y. Janjigian, MD; Joyce O’Shaughnessy, MD; Elizabeth R. Plimack, MD, MS and Tanguy Seiwert, MD, review important clinical presentations across multiple cancers from the 2017 oncology meeting in Madrid.
    Date Posted: 9/27/2017
  • Featured content
    Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, discuss the supporting rationale and emerging role of selective CDK4/6 inhibitors in multiple types of cancer.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 22 Shown
10 of 22 Shown
Show 10 More
Loading...